share_log

DEFA14A: Others

SEC ·  Nov 12 09:36

Summary by Moomoo AI

180 Life Sciences Corp. has announced the availability of proxy materials for its upcoming Annual Meeting of Stockholders scheduled for December 27, 2024. The meeting will be held online at 1:00 P.M. Pacific Time. Stockholders are encouraged to access and review the proxy materials available on the internet prior to voting. The agenda for the meeting includes the election of three Class II directors, the adoption of the third amendment to the company's charter, advisory resolutions on executive compensation, and approval of stock issuances for NASDAQ compliance. Additionally, the ratification of M&K CPAS, PLLC as independent auditors for the fiscal year ending December 31, 2024, will be addressed. The record date for stockholders entitled to vote has been set as October 31, 2024. The Board of Directors recommends voting 'for' all the proposals. Stockholders have until 11:59 PM Eastern Time on December 26, 2024, to submit their voting instructions online.
180 Life Sciences Corp. has announced the availability of proxy materials for its upcoming Annual Meeting of Stockholders scheduled for December 27, 2024. The meeting will be held online at 1:00 P.M. Pacific Time. Stockholders are encouraged to access and review the proxy materials available on the internet prior to voting. The agenda for the meeting includes the election of three Class II directors, the adoption of the third amendment to the company's charter, advisory resolutions on executive compensation, and approval of stock issuances for NASDAQ compliance. Additionally, the ratification of M&K CPAS, PLLC as independent auditors for the fiscal year ending December 31, 2024, will be addressed. The record date for stockholders entitled to vote has been set as October 31, 2024. The Board of Directors recommends voting 'for' all the proposals. Stockholders have until 11:59 PM Eastern Time on December 26, 2024, to submit their voting instructions online.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more